Outcomes of Patients Not Responding to Antibiotics in the Community

Completed · Not applicable

Conditions studied: Sinusitis, Bronchitis, Chronic, Pneumonia, Bacterial

In brief

A study to report the outcomes of patients who fail to respond to beta-lactam and macrolide antibiotics in the community

Key facts

Study ID

NCT00245427

Run by

CPL Associates

People needed

200

Starts

2005-12-01

Expected to finish

2006-03-01

Last updated by the study team

2007-10-31

Who can join

Age: any, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have failed to respond to at least three (ABECB and CAP) or five (AMS/ABRS/AECRS) days of macrolide or b-lactam therapy meeting all of the protocol criteria for acute bacterial exacerbations on chronic bronchitis(ABECB), community acquired pneumonia(CAP) and acute maxillary sinusitis(AMS) will be eligible for enrollment. All patients, whether enrolled retrospectively or concurrently, must have a positive culture. The pathogenic bacteria must be identified by a local laboratory and have a known susceptibility to the antibiotic class the patient failed to respond to (i.e. macrolide or b-lactam). The isolate must be sent to the Study Coordinating Center for precise MIC determination.

You may not qualify if…

• Patients presenting with any of the following will not be included in the study:
• Life expectancy <3 months from underlying disease
• Underlying lung carcinoma
• Cystic fibrosis

Where it is running

• Deaconess Medical School — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.